在β-血病基因疗法的进展:CRISPR/Cas系统和交付创新
Hongmei Liu1,2, Peng Zhang1
1Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Functional Nucleic Acids-Based Biopharmaceutical Research, Guizhou Biomanufacturing Laboratory, Guizhou Medical University, Guiyang 550031, China.
Cells
|October 28, 2025
概括
克里斯普尔基因编辑通过纠正HBB基因突变或提高胎儿血红蛋白,为beta-thalassemia提供了新的希望. 有效和安全的输送方法对于这些先进疗法的成功临床转化至关重要.
科学领域:
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
背景情况:
- β-thalassemia是一种严重的遗传性血液疾病,由于HBB基因突变导致慢性贫血.
- 目前的治疗方法,如输血和干细胞移植,在有效性和可访问性方面存在局限性.
研究的目的:
- 审查基于CRISPR的基因编辑对β-thalassemia的最新进展.
- 探索新的交付策略,以增强CRISPR的治疗应用.
主要方法:
- CRISPR-Cas9技术用于精确的基因校正或胎儿血红蛋白 (HbF) 的重新激活.
- 病毒和非病毒传递系统的评估 (例如,脂质纳米颗粒,外体).
主要成果:
- 克里斯普 (CRISPR) 方法对β-thalassemia显示出有希望的临床前和临床结果.
- 交付挑战,包括免疫性和向性,正在通过新的战略来解决.
结论:
- 基因编辑CRISPR对β-thalassemia具有显著的治疗潜力.
- 克服交付障碍是将这些创新治疗转化为临床实践的关键.
相关概念视频
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
CRISPR/Cas9 Genome Editing
1.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
What is Genetic Engineering?
79.6K
Overview
79.6K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928


